Week 8 slides
0 likes75 views
This document discusses various topics relating to technology and ethics, including social constructivism of technology, differing standards of ethics between cultures, and the role of marketing in reframing medical issues. It provides examples of how technologies like brochures can omit information and how stem cell companies capitalize on patient vulnerabilities. Questions are posed about whether scientific knowledge and technologies are fixed, whether people internalize beliefs of new cultures, and whether international standards are needed to govern transnational medical practices and regulate discrepancies.
Week 8 slides
- 1. Are you at Risk? Week 7 Tutorial Technological Artifacts IUD technologies Anni Dugdale Priscilla Song Stephanie Gabbie Paul Haikun Sonja Samantha
- 2. Anni Dugdale SCOT: Social Contructivism of Technology Technological Determinism “The political properties of technological”! !
- 3. Technoscience • Truths! • Scientific knowledge is also subject to social context! • Different Framing of Technologies! • Decentering of the subject
- 4. Transnational Bioethics ‘Beike’ • Priscilla Song, 2011! • Song explores the world of neurodegenerative treatments and how it has lead to the phenomena of ‘medical tourism’! • Differing standards of ethics! • Capitalization of human needs
- 5. Technologies of care Hype and Hope The way these companies close these discussions are implemented through marketing and repackaging of the product i.e. through new packaging or reframing of the problem. Beike, is a company that is using brochures to report on stem cell research. They capitalise of the hype of stem cell therapies and the vulnerabilities of patients. Brochures as a technology omit information to reframe the issue for the benefit of companies. Unethical because they do not give accurate information.
- 7. Questions 1. Are technologies and scientific knowledge fixed or do they oscillate? What would ‘challenge’ the meanings and fixity of these things? 2. Do people internalise and bring with them their own beliefs and attitudes when entering a new culture? 3. Does Asia have its own set of ‘bioethics’ which is significantly different from the dominant theories of ethics coming from Western ethics? 4. What happens to the standards of ethics when marketing/money conflate it? Can ethics and scientific validation be bought? 5. Is reframing a problem unethical? 6. These practices ultimately problematic the role of ethical regulation in governing transnational regimes of bioscience. Do we need a trnsanational standard of bioscience and ethics? Or is it enough to reply on the objective medical practices of other countries? What discrepancies do these gaps in the market create?